European Pharmaceutical Review

JANUARY 18, 2023

The first good manufacturing practice (GMP) registration of a UK pharmaceutical facility for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API) has been granted since the legalisation of medical cannabis in 2018. The firm’s medicinal cannabis product will be supplied in oil form as an API.

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies Labelling 119

pharmaphorum

JANUARY 17, 2022

Founded in 2018 as a spin-off of the University of Zurich and Harvard University, EraCal is already using this technology to develop a novel anti-obesity drug, named Era-379. Partnering with EraCal builds upon the success of Novo Nordisk’s Wegovy (semaglutide) chronic weight management drug, which was approved by the FDA in June 2021.

FDA 123

FDA Pharmaceutical Companies Pharmaceutical Companies 123

pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

European Pharmaceutical Review

FEBRUARY 21, 2023

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. There is a clear framework in place now, and as a pharmaceutical company, we are certainly not looking to the MHRA to loosen or change any of the guidelines.

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Compounding 132

European Pharmaceutical Review

AUGUST 1, 2022

The 2018 study of Phase III and IV clinical trials also identified additional barriers for disability diversity, including inaccessible trial sites, medical equipment and “ableist” biases. “The A study published in the Journal of the American Medical Association found that 12.4

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies FDA 122

European Pharmaceutical Review

SEPTEMBER 28, 2022

The method was able to detect, separate and quantify NDMA in the active pharmaceutical ingredient (API), manufactured tablets and marketed tablets. In 2018, one batch of the generic drug valsartan was recalled due to unacceptable levels of the nitrosamine impurity NDMA. González et al.

Compounding 105

Compounding Pharmaceutical Companies Pharmaceutical Companies FDA 105

European Pharmaceutical Review

JULY 12, 2022

More than 480 warning letters solely related to the failure to produce aseptic conditions because of deficient cleaning and disinfection systems for cleanrooms and their equipment, were issued by regulators between 2013 to 2018. Microbial resistance is one of the factors responsible for such failings.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies 111

Pharma Marketing Network

MAY 15, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

European Pharmaceutical Review

OCTOBER 24, 2022

The report found that consistently slow and variable study setup and recruitment timelines in the NHS are forcing some pharmaceutical companies to place their trials in other countries. This had increased by 25 days since 2018, which dropped the UK to 7 th place amongst comparator countries. “The

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies Patient Care Vaccines 91

The Checkup by Singlecare

MARCH 8, 2024

The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. Hyrimoz (adalimumab-adaz) Hyrimoz was the third Humira biosimilar , approved in October 2018 and available in the United States in July 2023.

Dosage 97

Dosage Pharmaceutical Companies Pharmaceutical Companies FDA 97

Pharma Marketing Network

MARCH 23, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance 69

Pharmaceutical Technology

AUGUST 1, 2022

For this, it will be necessary for governments to establish substantial incentive schemes to encourage pharmaceutical companies to invest more time, effort and money into antibiotic research. The most significant challenge, however, is solving the lack of market incentive.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies Chemotherapy 93

pharmaphorum

DECEMBER 15, 2020

There is a long-established synergistic relationship between larger, “innovation-driven” pharmaceutical companies and the generics industry in ensuring supply of established, but nevertheless essential, medicines. The pandemic has further highlighted how research is not strictly limited to large, “innovator” pharmaceutical companies.

Generic Medicine 93

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies Vaccines 93

pharmaphorum

AUGUST 25, 2022

The new partnership “marks a major milestone in Sonde Health’s growth and evolution,” according to the company’s chief executive David Liu.

Generic Medicine 84

Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 84

European Pharmaceutical Review

AUGUST 23, 2022

Second, pharmaceutical companies can implement serialisation of individual medicines, potentially tracking and tracing medicines to ensure brand protection. We believe that we need more scientists and researchers to work effectively at the intersection of academia, pharmaceutical companies and government agencies.

Dosage 98

Dosage Packaging Pharmaceutical Companies Pharmaceutical Companies 98

Pharmacy Is Right For Me

AUGUST 10, 2022

I have been in the pharmaceutical industry since 2007 and have been in various roles involving medical affairs and research and development. From 2015 through Jan 2018, I served as the U.S. What makes your career path unique? Medical Director for the HIV franchise. Before that, I served as Associate Medical Director of U.S.

Vaccines 130

Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

pharmaphorum

SEPTEMBER 16, 2020

Delayed clinical trial data delivery is a growing problem for pharmaceutical companies and one that can have catastrophic consequences for the development of their promising pipeline candidates. But there are ways to improve this situation, as Remarque Systems’ recent Is a lack of real-time data holding trials back?

Data Entry 71

Data Entry Pharmaceutical Companies Pharmaceutical Companies 71

European Pharmaceutical Review

SEPTEMBER 21, 2023

Pharmaceutical companies need to work closely with governments and health authorities to find innovative contracting and payment models, such as outcome-based agreements, which consider the clinical and economic value of the treatment to patients, healthcare systems and society. Anguela XM, High KA. Annu Rev Med. 2019; 70:273–288.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies FDA 96

pharmaphorum

OCTOBER 30, 2020

With COVID-19 anticipated to change how pharmaceutical companies engage with healthcare professionals, Ipsen UK&I is preparing for a more remote and virtual healthcare system. Prior to the pandemic, 95% of all the company’s UK customer facing teams’ interactions took place in person at NHS hospitals. “My Going remote.

Hospitals 126

Hospitals Pharmaceutical Companies Pharmaceutical Companies 126

pharmaphorum

JANUARY 6, 2023

So, what can a pharmaceutical company best control that directly affects its bottom line? When any organisation looks to slash its budget, the old adage about acquiring new customers costing five times as much as retaining existing customers becomes an alluring data point. in 1979 to 2.8%in Ensuring patient access.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

FEBRUARY 17, 2021

Few details about Haven emerged after the new venture was announced to the public in January 2018 and the Haven brand name did not appear until about a year later. CVS Health, Walmart, Cardinal Health and Express Scripts were among those affected. He told his guests, “We are not happy with healthcare costs and want to help.”

Insurance 126

Insurance Pharmaceutical Companies Pharmaceutical Companies 126

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness?

Documentation 119

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 119

Hospital Pharmacy Europe

AUGUST 17, 2023

1,2 CAR T-cell products, such as tisagenlecleucel and axicabtagene ciloleucel, have been available on the European market for clinical use since 2018 3-5 and are used to treat patients who have not responded to other first-line therapies. 8,9 Of the many stakeholders involved in CAR T therapy, pharmacists are crucial. GoCART Coalition.

Hospitals 98

Hospitals Documentation Chemotherapy Pharmaceutical Companies 98

Pharmaceutical Technology

APRIL 3, 2023

“Fruquintinib is an important treatment option for patients with metastatic CRC in China, where it has been available to patients since 2018. “We In January this year, HUTCHMED and the Takeda Pharmaceutical Company entered an exclusive licence agreement to develop and commercialise fruquintinib outside mainland China, Macau and Hong Kong.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 1, 2023

Venture financing for early-stage innovator drugs for biotech companies based in the Asia-Pacific (APAC) region between 2018 to 2022 received three times less funding, at $23bn, than their US counterparts, at $72bn, according to GlobalData’s Pharma Intelligence Centre Deals Database.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance 52

Roots Analysis

MARCH 26, 2024

However, the road for transition from the conventional batch to continuous manufacturing requires a shift in variety of parameters and is still quite unclear to many of the pharmaceutical companies. Whereas, two drugs received the PMDA approval, namely TRAMACET by Johnson and Johnson and VERZENIO® by Eli Lilly.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Omnicell

JANUARY 10, 2023

Before 2018, the reimbursement level was Average Sales Price (ASP) was more than plus 6 percent. From 2018 to the present, the reimbursement has been ASP minus 22.5 The pharmaceutical company notifies the hospital's drug supplier to resume supplying at a 340B discount. So, how does 340B ESP work?

Omnicell 52

Omnicell Hospitals Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

AUGUST 14, 2023

Swedish pharmaceutical company Vicore Pharma is developing treatments for diseases where the angiotensin II type 2 receptor (AT2R) has a central role in stopping and reversing disease pathology and where there is a large unmet medical need. The company’s lead candidate, C21, is an angiotensin II type 2 receptor agonist (ATRAG).

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling Immunization 98

pharmaphorum

SEPTEMBER 29, 2020

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies.

Chemotherapy 132

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 132

Roots Analysis

APRIL 20, 2022

2] Considering the aforementioned concerns, many pharmaceutical players now prefer to collaborate with qualified packaging providers that offer non-traditional packaging solutions and have the required capabilities to create unique packaging designs, in a cost and time effective manner. [3]

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Labelling 52

ISPE

SEPTEMBER 28, 2023

It's no wonder that global pharmaceutical companies are increasingly sourcing innovation through alliances and partnerships with their peers in California. California accounted for 15–18% of patents granted in core life sciences applications between 2018 and 2022.

Hospitals 98

Hospitals Documentation Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JULY 14, 2021

Critically, the risks of conduct related issues that weighed heavily on the reputation of pharmaceutical companies prior to COVID-19 have not gone away, for example the minimising of side effects, price manipulation, or healthcare system fraud amongst others. Compliance systems by themselves are not enough.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

Roots Analysis

DECEMBER 18, 2023

Subsequently, in mid-October 2018, Novartis acquired Endocyte, leveraging their prostate cancer product for further development. The Swedish pharmaceutical company, Oncopeptides was another developer which tapped into the next generation drug conjugate domain. More than 150 grants have been awarded within this domain from 2018.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies 40

PharmaShots

MAY 1, 2023

To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process. In this risk-taking venture, pharmaceutical companies rely massively on investors, venture capitalists, and government aid.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

PharmaShots

MAY 1, 2023

To keep up with the growing demands of drugs and vaccines on a global scale, companies invest heavily in technologies while constantly integrating innovations to facilitate the drug discovery process. In this risk-taking venture, pharmaceutical companies rely massively on investors, venture capitalists, and government aid.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40